Axel R Franz1,2, Corinna Engel1, Dirk Bassler3, Mario Rüdiger4, Ulrich H Thome5, Rolf F Maier6, Ingeborg Krägeloh-Mann7, Martina Kron8, Jochen Essers9, Christoph Bührer10, Georg Rellensmann11, Rainer Rossi12, Hans-Jörg Bittrich13, Claudia Roll14, Thomas Höhn15, Harald Ehrhardt16, Stefan Avenarius17, Hans Thorsten Körner18, Anja Stein19, Horst Buxmann20, Matthias Vochem21, Christian F Poets2. 1. Center for Pediatric Clinical Studies, University Children's Hospital Tübingen, Tübingen, Germany. 2. Neonatology, University Children's Hospital Tübingen, Tübingen, Germany. 3. University Hospital Zurich, Department of Neonatology, University of Zurich, Zurich, Switzerland. 4. Clinic for Pediatrics, Department for Neonatology and Pediatric Intensive Care Medicine, Medical Faculty, TU Dresden, Dresden, Germany. 5. Children's Hospital, Division of Neonatology, Department of Women and Children's Health, University of Leipzig, Leipzig, Germany. 6. Children's Hospital, University Hospital, Philipps University Marburg, Marburg, Germany. 7. Department of Paediatric Neurology and Developmental Medicine, University Children's Hospital Tübingen, Tübingen, Germany. 8. Institute for Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany. 9. University Hospital Ulm, Ulm, Germany. 10. Charité Universitätsmedizin Berlin, Berlin, Germany. 11. Pediatrics, University Hospital Münster, Münster, Germany. 12. Vivantes Klinikum Neukölln, Berlin, Germany. 13. Helios Klinikum Erfurt, Erfurt, Germany. 14. Vestische Kinder-und Jugendklinik Datteln, Universität Witten/Herdecke, Datteln, Germany. 15. Neonatology and Pediatric Intensive Care, University Hospital Düsseldorf, Düsseldorf, Germany. 16. Department of General Pediatrics and Neonatology, Justus-Liebig-University Giessen, Giessen, Germany. 17. Pediatrics, University Hospital Magdeburg, Magdeburg, Germany. 18. Neonatology, Klinikum Links der Weser, Bremen, Germany. 19. Department of Paediatrics I, University Duisburg-Essen, Essen, Germany. 20. University Hospital Frankfurt, Frankfurt, Germany. 21. Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
Abstract
Importance: Red blood cell transfusions are commonly administered to infants weighing less than 1000 g at birth. Evidence-based transfusion thresholds have not been established. Previous studies have suggested higher rates of cognitive impairment with restrictive transfusion thresholds. Objective: To compare the effect of liberal vs restrictive red blood cell transfusion strategies on death or disability. Design, Setting, and Participants: Randomized clinical trial conducted in 36 level III/IV neonatal intensive care units in Europe among 1013 infants with birth weights of 400 g to 999 g at less than 72 hours after birth; enrollment took place between July 14, 2011, and November 14, 2014, and follow-up was completed by January 15, 2018. Interventions: Infants were randomly assigned to liberal (n = 492) or restrictive (n = 521) red blood cell transfusion thresholds based on infants' postnatal age and current health state. Main Outcome and Measures: The primary outcome, measured at 24 months of corrected age, was death or disability, defined as any of cognitive deficit, cerebral palsy, or severe visual or hearing impairment. Secondary outcome measures included individual components of the primary outcome, complications of prematurity, and growth. Results: Among 1013 patients randomized (median gestational age at birth, 26.3 [interquartile range {IQR}, 24.9-27.6] weeks; 509 [50.2%] females), 928 (91.6%) completed the trial. Among infants in the liberal vs restrictive transfusion thresholds groups, respectively, incidence of any transfusion was 400/492 (81.3%) vs 315/521 (60.5%); median volume transfused was 40 mL (IQR, 16-73 mL) vs 19 mL (IQR, 0-46 mL); and weekly mean hematocrit was 3 percentage points higher with liberal thresholds. Among infants in the liberal vs restrictive thresholds groups, the primary outcome occurred in 200/450 (44.4%) vs 205/478 (42.9%), respectively, for a difference of 1.6% (95% CI, -4.8% to 7.9%; P = .72). Death by 24 months occurred in 38/460 (8.3%) vs 44/491 (9.0%), for a difference of -0.7% (95% CI, -4.3% to 2.9%; P = .70), cognitive deficit was observed in 154/410 (37.6%) vs 148/430 (34.4%), for a difference of 3.2% (95% CI, -3.3% to 9.6%; P = .47), and cerebral palsy occurred in 18/419 (4.3%) vs 25/443 (5.6%), for a difference of -1.3% (95% CI, -4.2% to 1.5%; P = .37), in the liberal vs the restrictive thresholds groups, respectively. In the liberal vs restrictive thresholds groups, necrotizing enterocolitis requiring surgical intervention occurred in 20/492 (4.1%) vs 28/518 (5.4%); bronchopulmonary dysplasia occurred in 130/458 (28.4%) vs 126/485 (26.0%); and treatment for retinopathy of prematurity was required in 41/472 (8.7%) vs 38/492 (7.7%). Growth at follow-up was also not significantly different between groups. Conclusions and Relevance: Among infants with birth weights of less than 1000 g, a strategy of liberal blood transfusions compared with restrictive transfusions did not reduce the likelihood of death or disability at 24 months of corrected age. Trial Registration: ClinicalTrials.gov Identifier: NCT01393496.
Importance: Red blood cell transfusions are commonly administered to infants weighing less than 1000 g at birth. Evidence-based transfusion thresholds have not been established. Previous studies have suggested higher rates of cognitive impairment with restrictive transfusion thresholds. Objective: To compare the effect of liberal vs restrictive red blood cell transfusion strategies on death or disability. Design, Setting, and Participants: Randomized clinical trial conducted in 36 level III/IV neonatal intensive care units in Europe among 1013 infants with birth weights of 400 g to 999 g at less than 72 hours after birth; enrollment took place between July 14, 2011, and November 14, 2014, and follow-up was completed by January 15, 2018. Interventions: Infants were randomly assigned to liberal (n = 492) or restrictive (n = 521) red blood cell transfusion thresholds based on infants' postnatal age and current health state. Main Outcome and Measures: The primary outcome, measured at 24 months of corrected age, was death or disability, defined as any of cognitive deficit, cerebral palsy, or severe visual or hearing impairment. Secondary outcome measures included individual components of the primary outcome, complications of prematurity, and growth. Results: Among 1013 patients randomized (median gestational age at birth, 26.3 [interquartile range {IQR}, 24.9-27.6] weeks; 509 [50.2%] females), 928 (91.6%) completed the trial. Among infants in the liberal vs restrictive transfusion thresholds groups, respectively, incidence of any transfusion was 400/492 (81.3%) vs 315/521 (60.5%); median volume transfused was 40 mL (IQR, 16-73 mL) vs 19 mL (IQR, 0-46 mL); and weekly mean hematocrit was 3 percentage points higher with liberal thresholds. Among infants in the liberal vs restrictive thresholds groups, the primary outcome occurred in 200/450 (44.4%) vs 205/478 (42.9%), respectively, for a difference of 1.6% (95% CI, -4.8% to 7.9%; P = .72). Death by 24 months occurred in 38/460 (8.3%) vs 44/491 (9.0%), for a difference of -0.7% (95% CI, -4.3% to 2.9%; P = .70), cognitive deficit was observed in 154/410 (37.6%) vs 148/430 (34.4%), for a difference of 3.2% (95% CI, -3.3% to 9.6%; P = .47), and cerebral palsy occurred in 18/419 (4.3%) vs 25/443 (5.6%), for a difference of -1.3% (95% CI, -4.2% to 1.5%; P = .37), in the liberal vs the restrictive thresholds groups, respectively. In the liberal vs restrictive thresholds groups, necrotizing enterocolitis requiring surgical intervention occurred in 20/492 (4.1%) vs 28/518 (5.4%); bronchopulmonary dysplasia occurred in 130/458 (28.4%) vs 126/485 (26.0%); and treatment for retinopathy of prematurity was required in 41/472 (8.7%) vs 38/492 (7.7%). Growth at follow-up was also not significantly different between groups. Conclusions and Relevance: Among infants with birth weights of less than 1000 g, a strategy of liberal blood transfusions compared with restrictive transfusions did not reduce the likelihood of death or disability at 24 months of corrected age. Trial Registration: ClinicalTrials.gov Identifier: NCT01393496.
Authors: Vickie L Baer; Diane K Lambert; Erick Henry; Gregory L Snow; Allison Butler; Robert D Christensen Journal: Transfusion Date: 2010-12-16 Impact factor: 3.157
Authors: Ursula Guillén; James J Cummings; Edward F Bell; Shigerharu Hosono; Axel R Frantz; Rolf F Maier; Robin K Whyte; Elaine Boyle; Max Vento; John A Widness; Haresh Kirpalani Journal: Semin Perinatol Date: 2012-08 Impact factor: 3.300
Authors: Amélia Miyashiro Nunes dos Santos; Ruth Guinsburg; Maria Fernanda Branco de Almeida; Renato S Procianoy; Cléa Rodrigues Leone; Sérgio Tadeu Martins Marba; Ligia Maria Suppo de Souza Rugolo; Humberto Holmer Fiori; José Maria de Andrade Lopes; Francisco Eulógio Martinez Journal: J Pediatr Date: 2011-04-13 Impact factor: 4.406
Authors: Robin K Whyte; Haresh Kirpalani; Elizabeth V Asztalos; Chad Andersen; Morris Blajchman; Nancy Heddle; Meena LaCorte; Charlene M T Robertson; Maxine C Clarke; Michael J Vincer; Lex W Doyle; Robin S Roberts Journal: Pediatrics Date: 2009-01 Impact factor: 7.124
Authors: Jacques Lacroix; Paul C Hébert; James S Hutchison; Heather A Hume; Marisa Tucci; Thierry Ducruet; France Gauvin; Jean-Paul Collet; Baruch J Toledano; Pierre Robillard; Ari Joffe; Dominique Biarent; Kathleen Meert; Mark J Peters Journal: N Engl J Med Date: 2007-04-19 Impact factor: 91.245
Authors: Orlyn C Lavilla; Khyzer B Aziz; Allison C Lure; Daniel Gipson; Diomel de la Cruz; James L Wynn Journal: Am J Respir Crit Care Med Date: 2022-01-01 Impact factor: 21.405
Authors: Nathan M Money; Alan R Schroeder; Ricardo A Quinonez; Timmy Ho; Jennifer R Marin; Elizabeth R Wolf; Daniel J Morgan; Sanket S Dhruva; Eric R Coon Journal: Pediatrics Date: 2022-02-01 Impact factor: 7.124
Authors: Ravi M Patel; Jeanne E Hendrickson; Marianne E Nellis; Rebecca Birch; Ruchika Goel; Oliver Karam; Matthew S Karafin; Sheila J Hanson; Bruce S Sachais; Ronald George Hauser; Naomi L C Luban; Jerome Gottschall; Cassandra D Josephson; Martha Sola-Visner Journal: J Pediatr Date: 2021-04-07 Impact factor: 6.314